LncRNA MEG3通过激活热亡信号通路,加剧了糖尿病心肌病
Shengnan Zhuo1, Yifeng Liu2, Siyuan Wang1
1School of Pharmacy, School of Food Science and Engineering, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Frontiers in pharmacology
|April 17, 2025
概括
长非编码RNA MEG3 (lncMEG3) 通过激活NLRP3炎症体,使糖尿病心肌病变化恶化. 在糖尿病小鼠中,抑制IncMEG3可降低炎症并改善心脏功能.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 糖尿病心肌病 (DCM) 是糖尿病的一个常见并发症.
- 长非编码RNA母性表达基因3 (lncMEG3) 与心脏病有关,但其在DCM中的作用尚不清楚.
研究的目的:
- 研究IncMEG3在DCM中的作用.
- 阐明 lncMEG3 在DCM中的功能背后的分子机制.
主要方法:
- 建立了一个糖尿病小鼠模型,使用链毒素 (STZ).
- 使用心脏向的腺相关病毒 (AAV9-shMEG3) 沉默 lncMEG3.
- 评估心脏功能通过心声回声学和心脏重塑通过H&E和马森三色彩染色.
- 分析了分子机制,使用西方斑块和qPCR.
主要成果:
- 在DCM心脏和高葡萄糖治疗心肌细胞中,lncMEG3表达升高.
- 在糖尿病小鼠中,IncMEG3绝杀改善了心脏功能,并减少了炎症,纤维化和缩.
- lncMEG3沉默抑制了NLRP3炎症酶激活.
- lncMEG3充当了miR-223的海绵,miR-223的抑制逆转了lncMEG3对NLRP3炎症组的击倒作用.
结论:
- lncMEG3通过促进NLRP3炎症酶激活来加剧DCM.
- 这通过减弱miR-223介导的NLRP3降解而发生.
- 针对 lncMEG3 可能为DCM提供治疗策略.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
468
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
10.0K
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
01:22PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
02:39lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K